US Hydroquinone markets extended a firm-to-bullish tone in February as upstream cost pressures were passed through and buyers front-loaded purchases ahead of seasonal demand. Early-month offers were lifted amid tighter feedstock dynamics and export competition reducing spot availability; by mid-to-late February, the market remained firm as photographic developers and cosmetics formulators advanced purchases and producers kept inventories lean ahead of planned Q2 turnarounds. Gulf Coast railcar congestion lengthened transit times, prompting sellers to prioritize higher-margin export loads under FOB Houston terms and sustaining a bullish trajectory into month-end. Demand across end-use sectors supported the gain, with photographic developers and formulators among the strongest buyers ahead of spring-season activity, and cosmetics players placing forward orders to mitigate potential regulatory lead-time extensions. Polymer and specialty-additive sectors provided modest support. Domestic capacity remains constrained, with lean inventories and export-driven tightness. Outlook remains bullish near term, with projected month-on-month gains of +15.7% in March, +9.1% in April and +5.5% in May, before moderating later.
